We have recently shown that a single intrathymic injection of syntheti
c 25mer peptides, representing full sequences of the hypervariable dom
ain of RT1.B-u beta (4 peptides) and RT1.D-u beta (4 peptides) WF clas
s II MHC molecules, 48 hr before transplantation induces donor-specifi
c unresponsiveness to WF rat renal allografts in adult LEW recipients.
The induction of unresponsiveness was abrogated by the recipient's th
ymectomy within the first week after intrathymic injection. Peripheral
T cells of long-term survivors exhibited antigen-specific hyporespons
iveness in the LEW x WF MLR. Studies on the mechanisms of induction of
acquired thymic unresponsiveness to alloantigen in vivo and in vitro
are now reported. First, since we have previously demonstrated in LEW
responders that only 4 of the 8 synthetic 25mer peptides, 2 RT1.D-u be
ta and 2 RT1.B-u beta sequences, were immunogenic in vitro and in vivo
, we compared the tolerogenicity of the immunogenic versus the nonimmu
nogenic peptides. While LEW rats intrathymically injected with the non
immunogenic peptides acutely rejected their renal allografts within 6-
10 days, animals injected with the immunogenic peptides did not reject
their grafts and are surviving >100 days with normal allograft functi
on. In vitro studies established that peripheral T cells from intrathy
mically tolerized animals exhibited antigen-specific hyporesponsivenes
s in the LEW x WF MLR starting as early as 1 week posttransplant. Immu
nohistological evaluation of renal allografts from intrathymically tol
erized animals 1 week postengraftment showed marked reduction in monon
uclear cell infiltrates with no evidence of tubulitis, and marked redu
ction in intragraft staining for activation and inflammatory cytokines
and alloantibodies, as compared with acutely rejecting controls. Syst
emic administration of 1000 U of rIL-2 daily for 5 days starting on th
e day of transplantation abrogated the tolerogenic effect of intrathym
ic MHC allopeptides. Injection of 100 mu g of a single immunogenic pep
tide, RT1.D-u beta 2 (residues 20-44), into the thymus of responder LE
W rats 48 hrs before immunization with RT1.D-u beta 2 effected signifi
cant reduction of in vitro proliferation of primed lymphocytes to RT1.
D-u beta 2, an effect that was abrogated by addition of rIL-2 in vitro
. In contrast, thymectomy beyond 2 weeks and administration of rIL-2 a
t 4-6 weeks after transplantation failed to cause rejection. These obs
ervations indicate that thymic recognition of immunodominant class II
MHC allopeptides leads to peripheral T cell anergy that mediates the i
nduction phase of systemic unresponsiveness to renal allografts. The m
aintenance phase appears to be mediated by dense anergy or clonal dele
tion. These findings also confirm the role of indirect T cell recognit
ion of alloantigen in vascularized allograft rejection, since function
al inactivation/deletion of T cells in this pathway is sufficient to p
revent rejection.